Dashboard
Discussions
Watchlists
Collections
Tools
More
Events
SIGN UP
SIGN IN
Sign in with Google
bullish
Joinn Laboratories China Lt
Watchlist
Joinn Laboratories (6127 HK) - Recovery Could Be Not Earlier than 1H24
Equity Bottom-Up
245 Views
02 Apr 2024 11:39
Broker
Joinn reported 2023 revenue of RMB2,376mn, up 4.8% YoY, and attributable net income of RMB338mn, down 66.9% YoY. The decelerated revenue growth was due to subdued R&D activities
SUMMARY
(Sign Up to Access)
Full Insight
(Paid Plans Only, 13-minute read)
Related Insights
More »
Loading
Trending Collections
More »
Index Rebalance
India
Event-Driven
Japan
Equity Bottom-Up
South Korea
China
Asia Event-Driven
Asia ECM
Sell / Short Ideas
Trending Insights
More »
Gold Miners ETF (GDX US): BIG Impact of Benchmark Change
Shin Kong (2888 TT)/Taishin (2887 TT) - Short Timer, FX Risk, Index Flows - Time To Buy Vs Peers
Vishal Mega Mart IPO Lockup Expiry - US$4bn Lockup Release with PE Sitting on 10x Gains
Santos (STO AU): XRG Consortium's Big Offer; Index Impact
MV Global Junior Gold Miners Index Rebalance: Stocks at Their Highs
Top Unpaywalled Insights
More »
Loading
Discussions
(Paid Plans Only)
Price Chart
(Sign Up to Access)
Insight Stream
Joinn Laboratories (6127 HK) - Recovery Could Be Not Earlier than 1H24
02 Apr 2024
Top
Who We Are
Careers
FAQs
Research Provider Solutions
Syndicate your Publications
Compliance
Terms of Use
Privacy Policy
Press Kit
RSS Feeds
Copyright © 2022 Smartkarma Innovations Pte Ltd. All Rights Reserved. v3.53.3
x